SCHEMBL4753845

SCHEMBL4753845

CC[C@H](CC(=O)OC)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.45
MAPK1 P28482 1/20 0.45
SLC1A1 P43005 2/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
CHRM1 P11229 1/20 0.41
AKR1A1 P14550 1/20 0.41
CHRM3 P20309 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1A P35348 1/20 0.41
HRH1 P35367 1/20 0.41
DRD3 P35462 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CA1 P00915 1/20 0.41
TSHR P16473 5/20 0.40
STING1 Q86WV6 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10597893 1.00 CA2 (0.45) CA2MAPK1SLC1A1SLC1A3SLC1A2
SCHEMBL8669433 0.88 SLC1A1 (0.47) CA2MAPK1SLC1A1CHRM1AKR1A1
SCHEMBL10980193 0.84 CA1 (0.42) CA2SLC1A1CA1TSHRUSP2
SCHEMBL3007122 0.83 CA2 (0.38) CA2MAPK1SLC1A1SLC1A3SLC1A2
SCHEMBL27514764 0.83 CHRM1 (0.60) CA2MAPK1SLC1A1SLC1A3SLC1A2
SCHEMBL9205076 0.82 CA1 (0.55) CA2CA1TSHRUSP2HSD17B10
SCHEMBL579960 0.82 CA1 (0.55) CA2CA1TSHRUSP2HSD17B10
SCHEMBL10259513 0.82 FOLH1 (0.46) SLC1A1TDP1TSHRHSD17B10MGAM
SCHEMBL8228378 0.80 CA1 (0.39) CA2SLC1A1CA1TSHRUSP2
SCHEMBL1823767 0.80 MGAM (0.46) CA2MAPK1SLC1A1SLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008155619-A2 PREPARATION OF OPTICALLY-ACTIVE CYCLIC AMINO ACIDS PFIZER INC. (US) 2008-12-24 WO disclosed
WO-2007139856-A2 HETEROBICYCLIC METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS, INC. (US) 2007-12-06 WO disclosed